The Effect of Antihypertensive Therapy on Left Ventricular Longitudinal Strain: Missing Part of the Puzzle

Marijana Tadic1, Cesare Cuspidi2

  • 1Department of Cardiology, University Clinical Hospital Center "Dr. Dragisa Misovic-Dedinje", Heroja Milana Tepica 1, Belgrade, 11000, Serbia. marijana_tadic@hotmail.com.

Insights

Antihypertensive therapy may improve left ventricular remodeling, but distinguishing medication effects from blood pressure reduction is challenging. Novel findings suggest mechanical changes initiate hypertensive heart disease remodeling, enabling earlier diagnosis.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Cardiac Physiology

Background:

  • The benefits of antihypertensive therapy on left ventricular (LV) structure and function lack consensus.
  • Most studies focus on LV hypertrophy, with less attention to diastolic dysfunction and mechanics.
  • Differentiating therapeutic effects from blood pressure reduction in LV improvement remains difficult.

Purpose of the Study:

  • To clarify the impact of antihypertensive therapy on LV structure, diastolic function, and mechanics.
  • To establish a new paradigm for understanding the sequence of LV remodeling in hypertensive heart disease.
  • To enable earlier diagnosis of subclinical LV damage and monitor treatment response.

Main Methods:

  • Review of existing studies on antihypertensive therapy and LV remodeling.
  • Analysis of the interplay between blood pressure, LV hypertrophy, diastolic dysfunction, and mechanics.
  • Investigation of the temporal sequence of LV changes in hypertensive heart disease.

Main Results:

  • Antihypertensive therapy generally promotes regression of LV remodeling.
  • A clear distinction between medication effects and blood pressure reduction on LV improvement is often obscured.
  • The sequence of LV remodeling in hypertensive heart disease appears to initiate with mechanical changes, followed by diastolic dysfunction, and culminating in hypertrophy.

Conclusions:

  • The proposed sequence of LV remodeling offers a new paradigm for early diagnosis of subclinical damage in hypertensive patients.
  • This understanding facilitates timely detection of LV function improvements during antihypertensive treatment.
  • Further research is needed to definitively separate the effects of antihypertensive medications from blood pressure reduction on LV parameters.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
601
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
828
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
302